Alpha-1-antitrypsin inhibits nitric oxide production (Q39279412)

10 September 2017

Alpha-1-antitrypsin inhibits nitric oxide production (English)

1 reference

10 September 2017

Philip E Silkoff

3

0 references

author name string

Edward D Chan

1

1 reference

10 September 2017

Gregory B Pott

2

1 reference

10 September 2017

Annemarie H Ralston

4

1 reference

10 September 2017

Courtney L Bryan

5

1 reference

10 September 2017

Leland Shapiro

6

1 reference

10 September 2017

13 September 2012

1 reference

Journal of Leukocyte Biology

10 September 2017

1 reference

10 September 2017

92

1 reference

10 September 2017

6

1 reference

10 September 2017

1251-1260

1 reference

Nitric oxide and the immune response

10 September 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Host defenses to Rickettsia rickettsii infection contribute to increased microvascular permeability in human cerebral endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Nitrate-nitrite-nitric oxide pathway: implications for anesthesiology and intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by α-1-antitrypsin through altered IκBα ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Redox signaling: nitrosylation and related target interactions of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Involvement and dual effects of nitric oxide in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

iNOS-mediated nitric oxide production and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

p38 Mitogen-activated protein kinase mediates synergistic induction of inducible nitric-oxide synthase by lipopolysaccharide and interferon-gamma through signal transducer and activator of transcription 1 Ser727 phosphorylation in murine aortic endo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Endothelial alpha-1-antitrypsin attenuates cigarette smoke induced apoptosis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Exhaled nitric oxide in pulmonary diseases: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Exhaled nitric oxide in patients with PiZZ phenotype-related alpha1-anti-trypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

The physiological role and pharmacological potential of nitric oxide in neutrophil activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Effect of expectoration on inflammation in induced sputum in alpha-1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Role of human neutrophil peptides in lung inflammation associated with α1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Macrophage biology and immunology: man is not a mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Sputum Dysplasia, Related to Bacterial Load, Oxidative Stress, and Airway Inflammation in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0212071

21 January 2018

Identifiers

DOI

10.1189/JLB.0212071

1 reference

10 September 2017

1 reference